We are live on ! Find out more
PM

Ponoi Management Portfolio holdings

AUM $73.2M
1-Year Est. Return 23.44%
This Fund
S&P 500
This Quarter Est. Return
-17.63%
1 Year Est. Return
-23.44%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$63.3M
AUM Growth
-$13.7M
Cap. Flow
+$11
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
NRIX icon
Nurix Therapeutics
NRIX
+$11

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RAPT
1
DELISTED
RAPT Therapeutics
RAPT
$29.2M 46.09%
199,927
– –
NGM
2
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$16.7M 26.29%
1,298,908
– –
RVMD icon
3
Revolution Medicines
RVMD
$47.4B
$13.4M 21.08%
685,011
– –
NRIX icon
4
Nurix Therapeutics
NRIX
$2.79B
$4.14M 6.54%
327,123
+1
+0% +$11

Similar funds

RC
Ronit Capital London, United Kingdom $74.3M AUM 13.35% 1-Year Est. Return
WM
Westpark Management Plano, Texas $75.3M AUM 22.07% 1-Year Est. Return
NVPX
Norwest Venture Partners XII Palo Alto, California $75.4M AUM 53.35% 1-Year Est. Return
FFMBT
First Farmers & Merchants Bank Trust Columbia, Tennessee $75.4M AUM 6.56% 1-Year Est. Return
SMC
S. Muoio & Co New York $75.7M AUM 42.51% 1-Year Est. Return
CCM
Composite Capital Management Hong Kong $70.1M AUM 79.53% 1-Year Est. Return
RA
Ratos AB Stockholm, Sweden $76.4M AUM
GI
Gavea Investimentos Rj, Brazil $77.6M AUM 64.56% 1-Year Est. Return

Ponoi Management's Q2 2022 Portfolio in Review

As of Q2 2022, Ponoi Management held 4 positions worth $63.3M, down 18% from $77M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 0%. Ponoi Management opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Ponoi Management added most to Nurix Therapeutics in Q2 2022, an estimated $11 increase.
  • Ponoi Management's ten largest holdings make up 100% of its $63.3M portfolio in Q2 2022.
  • Ponoi Management opened 0 new positions and closed 0 in Q2 2022.
  • Ponoi Management's portfolio value fell 18% quarter-over-quarter to $63.3M.

Based on Ponoi Management's 13F filing for Q2 2022, filed 15 Aug 2022.